id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-N-0385-0002,FDA,FDA-2003-N-0385,Draft Guidance,Supporting & Related Material,GDL-Guidance,2006-12-28T05:00:00Z,2006,12,,,2008-04-12T01:04:22Z,,0,0,090000648049a5e6
FDA-2003-N-0385-0006,FDA,FDA-2003-N-0385,Risk Assessment,Supporting & Related Material,RA-Regulatory Assessment,2006-12-28T05:00:00Z,2006,12,,,2008-04-12T01:04:22Z,,0,0,090000648049a5fe
FDA-2003-N-0385-0003,FDA,FDA-2003-N-0385,Draft Guidance,Supporting & Related Material,GDL-Guidance,2006-12-28T05:00:00Z,2006,12,,,2008-04-12T01:06:16Z,,0,0,090000648049a5f7
FDA-2003-N-0385-0001,FDA,FDA-2003-N-0385,FDA,Notice,NAD-Notice of Availability of Data,2006-12-28T05:00:00Z,2006,12,2006-12-28T05:00:00Z,2007-04-03T03:59:59Z,2008-04-12T01:03:44Z,,0,0,090000648049a462
FDA-2003-N-0385-0004,FDA,FDA-2003-N-0385,Risk Management Plan,Supporting & Related Material,BKG-Background Material,2006-12-28T05:00:00Z,2006,12,,,2008-04-12T01:05:02Z,,0,0,090000648049a5f9
FDA-2003-N-0385-0005,FDA,FDA-2003-N-0385,Risk Management Plan,Supporting & Related Material,BKG-Background Material,2006-12-28T05:00:00Z,2006,12,,,2008-04-12T01:06:52Z,,0,0,090000648049a5fc